Search - tctmd.com

Displaying 641 - 660 of 808

Sort: Relevancy | Date

Presentation TCT 2012

Orsiro (BIOTRONIK) Program Update

Presenter: Stephan Windecker

October 23, 2012

Presentation TCT 2012

Nanoparticle-Based Stents 2: FOCUS np (Envision Scientific) Program Update

Presenter: Ashok Seth

October 23, 2012

Presentation TCT 2012

Nanoparticle-Based Stents 1: Mitsui (Meril Life Sciences) Program Update

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

Inspiron (Scitech) Program Update

Presenter: Pedro Lemos

October 23, 2012

Presentation TCT 2012

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

Presenter: Stefan Verheye

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints

Presenter: John Ormiston

October 23, 2012

Presentation TCT 2012

Early Cellular Interaction and Biomaterials: Bioabsorbable Polymers and Advanced Metallic Surfaces Are the Next Logical Step!

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

DESyneBD (Elixir Medical) Program Update

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

Design of a Fully Drug-Eluting Bioabsorbable Scaffold with EPC-Capture Technology

Presenter: Robert Cottone

October 23, 2012

Presentation TCT 2012

Cre8 (CID) Program Update

Presenter: Didier Carri?

October 23, 2012

Presentation TCT 2012

BioMime (Meril Life Sciences) Program Update

Presenter: Ashok Seth

October 23, 2012

Presentation TCT 2012

Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety

Presenter: Ajay Kirtane

October 23, 2012

Presentation TCT 2012

Abluminus (Envision Scientific) Program Update

Presenter: Sameer Dani

October 23, 2012

Presentation TCT 2012

Vasomotion After Metallic and Bioabsorbable Implants: Evaluation and Clinical Relevance

Presenter: Ian Meredith

October 23, 2012

Presentation TCT 2012

The ART Stent: Design and Early First-in-Man Experiences

Presenter: Jean Fajadet

October 23, 2012

Presentation TCT 2012

The Amaranth Stent: Design and Future Directions

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

TCT-45. Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-world Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

Presenter: James Hermiller Jr

October 23, 2012

Presentation TCT 2012

Strut Architecture and Polymer Configuration Modulates Device Outcomes: Current Nonabsorbable DES Systems Will Be Difficult to Improve Upon!

Presenter: Elazer Edelman

October 23, 2012

Presentation TCT 2012

State of the Field Keynote: Impact of Emerging Biomaterials on Next-Generation Bioabsorbable Vascular Scaffold Development

Presenter: Syed Hossainy

October 23, 2012

Presentation TCT 2012

REVA - ReZolve Clinical Program Update

Presenter: Ricardo Costa

October 23, 2012

Advertisement

Orsiro (BIOTRONIK) Program Update

Nanoparticle-Based Stents 2: FOCUS np (Envision Scientific) Program Update

Nanoparticle-Based Stents 1: Mitsui (Meril Life Sciences) Program Update

Inspiron (Scitech) Program Update

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints

Early Cellular Interaction and Biomaterials: Bioabsorbable Polymers and Advanced Metallic Surfaces Are the Next Logical Step!

DESyneBD (Elixir Medical) Program Update

Design of a Fully Drug-Eluting Bioabsorbable Scaffold with EPC-Capture Technology

Cre8 (CID) Program Update

BioMime (Meril Life Sciences) Program Update

Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety

Abluminus (Envision Scientific) Program Update

Vasomotion After Metallic and Bioabsorbable Implants: Evaluation and Clinical Relevance

The ART Stent: Design and Early First-in-Man Experiences

The Amaranth Stent: Design and Future Directions

TCT-45. Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-world Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

Strut Architecture and Polymer Configuration Modulates Device Outcomes: Current Nonabsorbable DES Systems Will Be Difficult to Improve Upon!

State of the Field Keynote: Impact of Emerging Biomaterials on Next-Generation Bioabsorbable Vascular Scaffold Development

REVA - ReZolve Clinical Program Update

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content